Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Nyxoah

< Previous 1 2 3 Next >
Conditional Issuance of Shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Provides Update on FDA Approvable Letter for Genio System
From Nyxoah
Via GlobeNewswire
Tickers NYXH
FDA Issues Nyxoah an Approvable Letter for its Genio® System
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Reports Third Quarter Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Appoints John Landry as Chief Financial Officer
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Raises $27 Million through its At-the-Market Offering
From Nyxoah
Via GlobeNewswire
Tickers NYXH
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Participate in Upcoming Investor Conferences
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Nyxoah Appoints Scott Holstine as Chief Commercial Officer
From Nyxoah
Via GlobeNewswire
Tickers NYXH
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.